| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/13/2000 | EP1035205A1 Non-spreading pestivirus |
| 09/13/2000 | EP1035203A1 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants |
| 09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
| 09/13/2000 | EP1034254A1 Immortalized, homozygous stat1-deficient mammalian cell lines and their uses |
| 09/13/2000 | EP1034000A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection |
| 09/13/2000 | CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response |
| 09/12/2000 | US6117674 Pathogen propagation in cultured three-dimensional tissue mass |
| 09/12/2000 | US6117667 Method for producing an adapted virus population from an African green monkey kidney cell line |
| 09/12/2000 | CA2158024C A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof |
| 09/12/2000 | CA2021762C Antigens and methods therefor |
| 09/08/2000 | WO2000052188A1 Packaging cells for retroviral vectors |
| 09/08/2000 | WO2000052187A2 Enhanced system for construction of adenovirus vectors |
| 09/08/2000 | WO2000017377A3 Methods for large-scale production of recombinant aav vectors |
| 09/08/2000 | WO2000015853A9 Recombinant newcastle disease virus rna expression systems and vaccines |
| 09/08/2000 | WO2000014205A9 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 09/07/2000 | DE19909769A1 Von SIVagm abgeleitete lentivirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in Säugerzellen Of SIVagm-derived lentiviral vectors, processes for their preparation and their use for gene transfer into mammalian cells |
| 09/06/2000 | EP1032697A1 High efficiency retroviral vectors that contain none of viral coding sequences |
| 09/06/2000 | EP1032696A1 Vector for tissue-specific replication and gene expression |
| 09/06/2000 | EP1032695A2 Adenovirus vectors and method for reducing homologous recombination phenomena |
| 09/06/2000 | EP1032653A1 Serum-free, low-protein media for rotavirus vaccine production |
| 09/06/2000 | EP1032369A1 Targeted liposome gene delivery |
| 09/06/2000 | EP1032269A1 Treatment of neoplasms with viruses |
| 09/05/2000 | US6114141 Contacting host cell with conditionally replicating virus vector and a wild-type virus, a helper virus, or a helper vector; then expressing gene; prophylactic and therapeutic treatment of human immunodeficiency virus |
| 09/05/2000 | US6114110 Isolation and propagation of a human herpesvirus derived from AIDS-associated Kaposi's sarcoma cells |
| 09/05/2000 | US6114108 Methods and compositions for the selective modification of viral nucleic acids |
| 09/05/2000 | US6113913 Genomes and gene codes |
| 09/05/2000 | US6113912 Hepatitis A virus vaccines |
| 09/05/2000 | US6113910 Vaccines for gastroenteritis in humans |
| 09/05/2000 | CA2298892A1 Lentiviral vectors derived from sivagm, methods for their preparation and their use for gene transfer into mammalian cells |
| 09/05/2000 | CA1341091C Regulation of gene expression by employing translational inhibition utilizaing mrna interfering complementary rna |
| 08/31/2000 | WO2000050619A1 Adenovirus mutants with deleted protease gene, complementing cell lines and corresponding vectors for gene transfer |
| 08/31/2000 | WO2000050618A1 Virus vector |
| 08/31/2000 | WO2000050603A1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 08/31/2000 | WO2000050573A1 Method for obtaining a purified viral preparation |
| 08/31/2000 | WO2000050051A2 Reovirus for the treatment of cellular proliferative disorders |
| 08/31/2000 | WO2000028040A3 Cloning of rhadinovirus genome and methods for its use |
| 08/31/2000 | WO2000023465A3 Methods and reagents for isolating biologically active peptides |
| 08/31/2000 | WO2000018906A9 Shuffling of codon altered genes |
| 08/31/2000 | CA2615684A1 Reovirus for the treatment of cellular proliferative disorders |
| 08/31/2000 | CA2365026A1 Virus vector |
| 08/30/2000 | EP1030928A1 Development of viruses resistant to inactivation by the human complement system |
| 08/30/2000 | EP1030861A1 Modification of virus tropism and host range by viral genome shuffling |
| 08/30/2000 | CN1055968C Colon bacillus cytosine ammonialyse gene and new substance containing same |
| 08/29/2000 | US6110744 Diminishing viral gene expression by promoter replacement |
| 08/29/2000 | US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | US6110468 Respiratory syndrome virus for swine |
| 08/29/2000 | US6110467 Isolated porcine respiratory and reproductive virus, vaccines and methods of protecting a pig against a disease caused by a porcine respiratory and reproductive virus |
| 08/29/2000 | US6110466 Modified plant viruses as vectors |
| 08/29/2000 | US6110461 Reovirus for the treatment of neoplasia |
| 08/24/2000 | WO2000049166A2 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 08/24/2000 | WO2000048703A1 Purification of biological substances |
| 08/24/2000 | CA2645398A1 Universal plasma from antibodies-depleted blood |
| 08/24/2000 | CA2363061A1 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 08/23/2000 | EP1029068A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 08/23/2000 | EP1028742A1 Host derived proteins binding hcv: medical, diagnostic and purification use |
| 08/23/2000 | CN1263945A American pig reproduction and respiratory syndrome (PRRS) virus and its use |
| 08/23/2000 | CN1055726C Reconstituted body vaccine and method for prepn. thereof |
| 08/22/2000 | US6107086 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 08/22/2000 | US6107077 Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines |
| 08/22/2000 | US6107062 Antisense viruses and antisense-ribozyme viruses |
| 08/22/2000 | US6107028 Prevention of viral replication or expression; insertion of a expression vector coding ribonucleic acid preferential proteolytic enzyme into cells infected with virus |
| 08/22/2000 | US6107027 Supression of viral gene expression in cells; transducing cells with a adenovirus vector which codes a protein which has preferential proteolytic activity for ribonucleic acids |
| 08/22/2000 | US6106825 Gene expression |
| 08/17/2000 | WO2000047757A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
| 08/17/2000 | WO2000047756A1 Recombined porcine adenovirus based viral vaccines and vectors |
| 08/17/2000 | WO2000047240A1 Methods of inactivating pathogens using broad-spectrum pulsed light |
| 08/17/2000 | DE19905501A1 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament |
| 08/17/2000 | CA2360131A1 Methods of inactivating pathogens using broad-spectrum pulsed light |
| 08/17/2000 | CA2359748A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
| 08/16/2000 | EP1027075A1 Gene therapy for stimulation of angiogenesis |
| 08/16/2000 | EP1027071A2 Encapsulated immunomodulators useful as vaccine adjuvants |
| 08/16/2000 | CN1263159A New type simple herpesvirus amplicon carrier system and its application |
| 08/16/2000 | CN1055501C Recombinant avipox virus, culture of cells infected by this virus and vaccines for poultry derived from this virus |
| 08/15/2000 | US6103494 Nucleotide sequences which code protein associated with immmune response; for the detection of flea allergy dermatitis; for the detection of modulators of immune response |
| 08/15/2000 | US6103244 Containing a heterologous insert encoding an immunogenic protein, wherein said insert was molecularly cloned directly into the viral genome into a unique restriction endonuclease cleavage site |
| 08/10/2000 | WO2000046364A1 Fiber receptor-independent system for the propagation of adenoviral vectors |
| 08/10/2000 | WO2000046360A1 Improved helper dependent vector system for gene therapy |
| 08/10/2000 | WO2000046355A2 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 08/10/2000 | WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 08/10/2000 | CA2360796A1 Improved helper dependent vector system for gene therapy |
| 08/09/2000 | EP1026246A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| 08/09/2000 | EP1026240A2 Generation and selection of recombinant varied binding proteins |
| 08/09/2000 | EP1025251A1 Amplifiable adeno-associated virus (aav) packaging cassettes for the production of recombinant aav vectors |
| 08/09/2000 | EP1025243A2 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS |
| 08/09/2000 | EP1025209A1 An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
| 08/09/2000 | EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR |
| 08/08/2000 | US6100242 Gene therapies for enhancing cardiac function |
| 08/08/2000 | US6100088 Viral vaccines |
| 08/08/2000 | US6100068 Method of protein production using mitochondrial translation system |
| 08/08/2000 | US6099847 Genetic eengineering |
| 08/03/2000 | WO2000044884A1 Bhv-1 gene-deleted virus vaccine |
| 08/03/2000 | WO2000044883A1 Propagation of bovine coronavirus in chinese hamster ovary cells |
| 08/03/2000 | WO2000022137A3 Selectively replicating viral vectors |
| 08/03/2000 | WO2000014240A3 Attenuated salmonella sp12 mutants as antigen carriers |
| 08/03/2000 | WO2000008131A9 Pseudotyped retroviruses and stable cell lines for their production |
| 08/03/2000 | WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof |
| 08/03/2000 | WO2000000617A9 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 08/03/2000 | WO1999055366A8 Chimeras of hepatitis c virus and bovine viral diarrhea virus |
| 08/02/2000 | EP1024191A2 Production of chimeric antibodies from antibody segment repertoires and displayed on phage |